The chief executive of the pharmaceutical giant, Thomas Schinecker, disclosed this on Tuesday.
Mr Schinecker said that the commitment includes new state-of-the-art research and development sites and new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California.
He also said that the investments were expected to create more than 12,000 new jobs, including nearly 6,500 construction jobs and 1,000 jobs at new and expanded facilities.
He explained that the added capacity would allow the company to export more medicines from the U.S. than it imports.
”The investments underscore our long-standing commitment to research, development and manufacturing in the U.S.,” Mr Schinecker said.
Roche is a Swiss company with a strong heritage in more than 130 countries globally.
